Precigen Inc. Director Jeffrey B Kindler Sells Shares in Two Transactions.

Precigen, Inc. [PGEN] has disclosed that Director Jeffrey B. Kindler has sold 67,523 shares at $3.6 per share on September 29, 2025, and sold an additional 106,837 shares at $3.38 per share on September 30, 2025.

Precigen, Inc. [PGEN] has disclosed significant insider trading activity involving its Director, Jeffrey B. Kindler. On September 29, 2025, Kindler sold 67,523 shares at $3.6 per share, and on September 30, 2025, he sold an additional 106,837 shares at $3.38 per share. This trading activity has sparked interest among investors and financial professionals.

The total value of shares sold by Kindler on September 29, 2025, amounts to $241,861 (67,523 shares * $3.6 per share). On September 30, 2025, the value of shares sold by Kindler is $358,223 (106,837 shares * $3.38 per share). The combined value of shares sold by Kindler over the two days totals $600,084.

These transactions were disclosed in SEC filings, which are publicly available. Insider trading regulations require that insiders, such as directors, disclose their trades within a specified period to maintain transparency and trust among investors. The SEC filings also provide insights into the company's financial health and the market's perception of its prospects.

The recent insider trading activity by Director Jeffrey B. Kindler is a significant event for Precigen, Inc. [PGEN] shareholders. While the trades themselves do not necessarily indicate a change in the company's prospects, they can influence market sentiment and stock price movements. Investors should closely monitor the company's financial performance and any further insider trading activities to make informed investment decisions.